| Literature DB >> 14572383 |
Abstract
These guidelines resume different issues related to the clinical management of invasive candidosis in the immunossuppressed patients. They are based on the recommendations of the different Drug's Agencies.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14572383 DOI: 10.1016/s0213-005x(03)72995-4
Source DB: PubMed Journal: Enferm Infecc Microbiol Clin ISSN: 0213-005X Impact factor: 1.731